Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    "West nile virus"
Show Display Options
RSS Create an RSS feed from your search for:
"West nile virus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed West Nile Virus Natural History
Condition: West Nile Virus
2 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
3 Terminated
Has Results
Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis;   West Nile Fever
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
4 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
5 Completed Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Condition: West Nile Virus
Intervention: Drug: Omr-IgG-am
6 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
7 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Polygam® S/D;   Drug: Placebo
8 Completed A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults
Condition: West Nile Virus
Interventions: Drug: MGAWN1;   Other: Placebo
9 Completed Safety Study of HBV-002 West Nile Vaccine in Healthy Adults
Condition: West Nile Virus Disease
Intervention: Biological: WN-80E
10 Completed Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
Condition: West Nile Virus
Intervention: Drug: AVI-4020 Injection
11 Completed Phase I Study of West Nile Virus Vaccine
Condition: West Nile Fever
Intervention: Drug: VRC-WNVDNA020-00-VP
12 Completed Retrovirus Epidemiology Donor Study-II (REDS-II)
Conditions: Acquired Immunodeficiency Syndrome;   Blood Donors;   Blood Transfusion;   HIV Infections;   HIV-1;   HIV-2;   HTLV-I;   HTLV-II;   Retroviridae Infections;   Hepatitis, Viral, Human;   Hepatitis B;   Hepacivirus;   West Nile Virus
13 Completed Vaccine to Prevent West Nile Virus Disease
Conditions: Healthy;   West Nile Fever;   Healthy Volunteer;   HV
Intervention: Drug: VRC-WNVDNA017-00-VP
14 Terminated An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever
Intervention: Drug: AVI-4020 Injection
15 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
16 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
17 Completed
Has Results
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 vaccine;   Biological: Placebo

Indicates status has not been verified in more than two years